Company Profile For Covidien plc.

Covidien plc. (COV.N) (New York Stock Exchange)
sector: Healthcare · industry: Medical Equipment, Supplies & Distribution ·
As of  27 Nov 2009
46.96USD
Price Change
-0.39
Percent Change
-0.82%
 
 
Research a stock:   symbol lookup

Overview

Covidien Public Limited Company, formerly Covidien Ltd. is engaged in the development, manufacture and sale of healthcare products for use in clinical and home settings. The Company operates in three business segments: medical devices, pharmaceuticals and medical supplies. The medical devices segment includes the development, manufacture and sale of endomechanical instruments, soft tissue repair products, energy devices, oximetry and monitoring products, airway and ventilation products, products used in vascular therapies and other medical products. The pharmaceuticals segment includes the development, manufacture and distribution of specialty pharmaceuticals, active pharmaceutical ingredients, specialty chemicals, contrast products and radiopharmaceuticals. The medical supplies segment includes the development, manufacture and sale of nursing care products, medical surgical products, SharpSafety products and original equipment manufacturer products (OEM).

Quick Financial Synopsis

BRIEF: For the fiscal year ended 25 September 2009, Covidien PLC's revenues increased 3% to $10.68B. Net income from continuing operations decreased 41% to $902M. Revenues reflect an increase in income from medical devices and higher revenue from pharmaceutical product segment. Net income was offset by an increase in selling, general & administration expenses and higher research & development expenses.

Company Address

Covidien plc.
Block G, First Floor
Cherrywood Business Park
Co. Dublin    

Total Employees

41800

Find Out More About COV.N

Market Update

  • UKUK
  • USUS
  • Europe
  • Asia
  • UK Most Actives
advertisement